Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use

E J Pappert1, C Buhrfiend, J W Lipton

  • 1Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.

Movement Disorders : Official Journal of the Movement Disorder Society
|January 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of morning bradykinesia in Parkinson's disease in a United States cohort using continuous objective monitoring.

Clinical parkinsonism & related disorders·2022
Same author

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Movement disorders : official journal of the Movement Disorder Society·2017
Same author

Revue neurologique·2017
Same author

Charcot, hysteria, and simulated disorders.

Handbook of clinical neurology·2016
Same author

Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.

European journal of neurology·2014
Same author

Continuous in-home monitoring of essential tremor.

Parkinsonism & related disorders·2013

Levodopa/carbidopa (LD/CD) solution stability is limited at room temperature but prolonged by ascorbate. Refrigeration or freezing maintains LD/CD stability for 7 days, with light having no impact.

Area of Science:

  • Pharmaceutical Science
  • Drug Stability
  • Formulation Development

Background:

  • Levodopa/carbidopa (LD/CD) is a critical treatment for Parkinson's disease.
  • Understanding the stability of compounded LD/CD solutions is essential for effective patient care.
  • Limited data exists on the optimal storage conditions for extemporaneously prepared LD/CD solutions.

Purpose of the Study:

  • To define the temporal stability characteristics of levodopa/carbidopa (LD/CD) solutions.
  • To determine the effects of temperature, ascorbate, and light on LD stability over a 7-day period.

Main Methods:

  • LD/CD solutions were prepared and stored under various conditions: room temperature, refrigeration, and freezing.
  • Stability was assessed over 7 days by measuring LD levels.

Related Experiment Videos

  • The influence of ascorbate and light (or darkness) on LD stability was evaluated.

    • Main Results:

    • At room temperature without ascorbate, LD levels significantly declined by 48 hours.
    • Ascorbate addition prolonged LD/CD solution stability to 72 hours at room temperature.
    • Refrigeration and freezing prevented significant LD decline for the entire 7-day study period.
    • Light exposure did not affect LD/CD solution stability.

    Conclusions:

    • Daily preparation of LD/CD solution requires no special handling under standard conditions.
    • Incorporating ascorbate, refrigeration, or freezing significantly enhances the stability of LD/CD solutions.
    • These findings support optimized storage recommendations for compounded LD/CD formulations to ensure therapeutic efficacy.